Wang, J., Lu, K., Song, Y., Zhao, S., Ma, W., Xuan, Q., . . . Zhang, Q. (2015). RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. PLoS One.
シカゴスタイル引用形Wang, Jingxuan, et al. "RANKL and OPG Polymorphisms Are Associated With Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients." PLoS One 2015.
MLA引用形式Wang, Jingxuan, et al. "RANKL and OPG Polymorphisms Are Associated With Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients." PLoS One 2015.
警告: この引用は必ずしも正確ではありません.